120 related articles for article (PubMed ID: 17392740)
21. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
22. Hippocampal memory system function and the regulation of cocaine self-administration behavior in rats.
Black YD; Green-Jordan K; Eichenbaum HB; Kantak KM
Behav Brain Res; 2004 May; 151(1-2):225-38. PubMed ID: 15084439
[TBL] [Abstract][Full Text] [Related]
23. Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats.
Deiana S; Fattore L; Spano MS; Cossu G; Porcu E; Fadda P; Fratta W
Neuropharmacology; 2007 Feb; 52(2):646-54. PubMed ID: 17098261
[TBL] [Abstract][Full Text] [Related]
24. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats.
Koeltzow TE; Vezina P
Behav Brain Res; 2005 May; 160(2):250-9. PubMed ID: 15863221
[TBL] [Abstract][Full Text] [Related]
25. The cannabinoid receptor agonist WIN 55,212-2 facilitates the extinction of contextual fear memory and spatial memory in rats.
Pamplona FA; Prediger RD; Pandolfo P; Takahashi RN
Psychopharmacology (Berl); 2006 Nov; 188(4):641-9. PubMed ID: 16947018
[TBL] [Abstract][Full Text] [Related]
26. First in vivo evidence for a functional interaction between chemokine and cannabinoid systems in the brain.
Benamar K; Geller EB; Adler MW
J Pharmacol Exp Ther; 2008 May; 325(2):641-5. PubMed ID: 18281594
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Neuroscience; 2015 Sep; 303():149-59. PubMed ID: 26135674
[TBL] [Abstract][Full Text] [Related]
28. Somatic and anxiety-like behaviors in male and female rats during withdrawal from the non-selective cannabinoid agonist WIN 55,212-2.
Brewer AL; Felter CE; Sternitzky AR; Spencer SM
Pharmacol Biochem Behav; 2024 Mar; 236():173707. PubMed ID: 38244864
[TBL] [Abstract][Full Text] [Related]
29. Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in vivo microdialysis study in the awake rat.
Antonelli T; Tanganelli S; Tomasini MC; Finetti S; Trabace L; Steardo L; Sabino V; Carratu MR; Cuomo V; Ferraro L
Neuroscience; 2004; 124(2):367-75. PubMed ID: 14980386
[TBL] [Abstract][Full Text] [Related]
30. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats.
Drews E; Schneider M; Koch M
Pharmacol Biochem Behav; 2005 Jan; 80(1):145-50. PubMed ID: 15652390
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
[TBL] [Abstract][Full Text] [Related]
32. Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis.
Alén F; Mouret A; Viveros MP; Llorente R; Lepousez G; Lledo PM; López-Moreno JA
Int J Neuropsychopharmacol; 2010 Mar; 13(2):191-205. PubMed ID: 20047713
[TBL] [Abstract][Full Text] [Related]
33. WIN 55,212-2 decreases the reinforcing actions of cocaine through CB1 cannabinoid receptor stimulation.
Vlachou S; Nomikos GG; Panagis G
Behav Brain Res; 2003 May; 141(2):215-22. PubMed ID: 12742258
[TBL] [Abstract][Full Text] [Related]
34. Effects of serotonin (5-HT)(1B) receptor ligands on cocaine-seeking behavior in rats.
Przegaliński E; Gołda A; Filip M
Pharmacol Rep; 2008; 60(6):798-810. PubMed ID: 19211971
[TBL] [Abstract][Full Text] [Related]
35. Gestational treatment with methylazoxymethanol (MAM) that disrupts hippocampal-dependent memory does not alter behavioural response to cocaine.
Featherstone RE; Burton CL; Coppa-Hopman R; Rizos Z; Sinyard J; Kapur S; Fletcher PJ
Pharmacol Biochem Behav; 2009 Oct; 93(4):382-90. PubMed ID: 19467255
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling.
Su SH; Wu YF; Lin Q; Yu F; Hai J
Neuroscience; 2015 Aug; 301():563-75. PubMed ID: 25795598
[TBL] [Abstract][Full Text] [Related]
37. A cannabinoid agonist, WIN 55,212-2, reduces neuropathic nociception induced by paclitaxel in rats.
Pascual D; Goicoechea C; Suardíaz M; Martín MI
Pain; 2005 Nov; 118(1-2):23-34. PubMed ID: 16213089
[TBL] [Abstract][Full Text] [Related]
38. Potentiated reinstatement of cocaine-seeking behavior following D-amphetamine infusion into the basolateral amygdala.
Ledford CC; Fuchs RA; See RE
Neuropsychopharmacology; 2003 Oct; 28(10):1721-9. PubMed ID: 12865896
[TBL] [Abstract][Full Text] [Related]
39. Cocaine seeking over extended withdrawal periods in rats: time dependent increases of responding induced by heroin priming over the first 3 months.
Lu L; Dempsey J
Psychopharmacology (Berl); 2004 Oct; 176(1):109-14. PubMed ID: 15071720
[TBL] [Abstract][Full Text] [Related]
40. Aripiprazole blocks reinstatement of cocaine seeking in an animal model of relapse.
Feltenstein MW; Altar CA; See RE
Biol Psychiatry; 2007 Mar; 61(5):582-90. PubMed ID: 16806092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
